|
⚲
|
| Floratine Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001437628 |
| Sale | 2010-03-16 ($11.0 M Offered, $9.4 M Sold) |
| Fund | |
| Phone | 9012211200 |
| Address | 153 North Main Street Collierville, 38017 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Caldwell Lowrance | |
| David Zaleski | |
| Brian Goodwin | |
| Peter Stromberg |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
ASQI Emerging Markets Fund, LP
✚
|
0.0 | |
|
Assadi Hamideh
✚
|
0.0 | |
|
Asset Resurgence Mauritius Fund
✚
|
0.0 | |
|
Assure, a Series of Jason's Syndicate, LLC
✚
|
0.0 | |
|
Astea International Inc
✚
|
0.0 | |
|
Astignes Asia Rates Compass Fund Ltd.
✚
|
0.0 | |
|
AST & Science, LLC
✚
|
0.0 | |
|
Asymmetria Investors II, LLC - Series 2
✚
|
0.0 | |
|
Asymmetria Investors II, LLC - Series 3
✚
|
0.0 | |
|
Aspire Ventures Precision Medicine Fund, LLC
✚
|
0.0 |